Skip to Content

Mayo Clinic study finds long-term survival “often possible” for advanced pancreatic cancer patients

ROCHESTER, Minn. (KTTC) – Mayo Clinic researchers are providing a source of hope for those diagnosed with advanced pancreatic cancer.

A Mayo Clinic study published Tuesday goes against conventional wisdom, finding long-term survival is often possible.

The study followed 194 Mayo Clinic patients who received chemotherapy followed by radiation and then surgery.

Researchers say 12 to 18 months is a common survival time suggested after the diagnosis, but in their study, the average survival time reached nearly sixty months.

That extended time is due to three factors: extended chemotherapy before surgery, a tumor marker that fell to normal level after chemotherapy, and a tumor that was found mostly dead after removal.

The authors hope this news convinces doctors that long term survival is possible if their patients receive appropriate treatment.

The study was published in Annals of Surgery.

Jacob Murphey

Skip to content